Skip to main content
SpringerLink
Log in

Treatment Strategies for Refractory Status Epilepticus

  • Chapter
  • First Online:
Refractory Status Epilepticus

  • 736 Accesses

Abstract

Treatment strategies for refractory status epilepticus (RSE) consist of two phases, including the termination of RSE onset and addressing the secondary damage induced by status epilepticus (SE). In this chapter, we provide a detailed introduction regarding how therapies to treat RSE are chosen, how these treatments are administered, the precautions that should be taken, and the potential problems that can arise during their use. We also summarize the characteristics of the pathophysiological processes underlying SE, discuss how they affect the functions of different organs, and describe the corresponding countermeasures to these effects. The hope is that once the onset of RSE has been terminated, any secondary damage can simultaneously be reduced as much as possible. These efforts are aimed at achieving a state of stable vital signs in the patient, ensuring the presence of good perfusion and functioning in important organs, and, most importantly, decreasing the death rate and increasing the cure rate in patients with RSE.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wilkes R, Tasker RD. Intensive care treatment of uncontrolled status epilepticus in children: systematic literature search of midazolam and anesthetic therapies. Pediatr Crit Care Med. 2014;15(7):632–9.

    Article  PubMed  Google Scholar 

  2. Ozdemir D, Gulez P, Uran N, Yendur G, Kavakli T, Aydin A. Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus. Seizure. 2005;14(2):129–32.

    Article  PubMed  Google Scholar 

  3. Gaspard N, Foreman B, Judd LM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54:1498–503.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Rosati A, Erario LM, Ilvento L, Cecchi C, Pisano T, Mirabile L, Guerrini R. Efficacy and safety of ketamine in refractory status epilepticus in children. Neurology. 2012;11(79):2355–8.

    Article  Google Scholar 

  5. Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res. 2000;42:117–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Synowiec AS, Singh DS, Yenugadhati V, Valereriano JP, Schramke CJ, Kelly KM. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res. 2013;105:183–8.

    Article  CAS  PubMed  Google Scholar 

  7. Basha MM, Alqallaf A, Shah AK. Drug-induced EEG pattern predicts effectiveness of ketamine in treating refractory status epilepticus. Epilepsia. 2015;56(4):e44–8.

    Article  CAS  PubMed  Google Scholar 

  8. Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure. 2015;30:14–20.

    Article  PubMed  Google Scholar 

  9. Wang X, Jin J, Chen R. Combination drug therapy for the treatment of status epilepticus. Expert Rev Neurother. 2015;15(6):639–54.

    Article  CAS  PubMed  Google Scholar 

  10. Wasterlain CG, Chen JW. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia. 2008;49(Suppl 9):63–73.

    Article  CAS  PubMed  Google Scholar 

  11. Silbergleit R, Lowenstein D, Durkalski V, Conwit R. RAMPART (rapid anticonvulsant medication prior to arrival trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics. Epilepsia. 2011;52(Suppl 8):45–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Mazarati AM, Baldwin R, Klitgaard H, Matagne A, Wasterlain CG. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epilepsy Res. 2004;58(2–3):167–74.

    Article  CAS  PubMed  Google Scholar 

  13. Uges JW, van Huizen MD, Engelsman J, Wilms EB, Touw DJ, Peeters E, et al. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus. Epilepsia. 2009;50(3):415–21.

    Article  CAS  PubMed  Google Scholar 

  14. Gallentine WB, Hunnicutt AS, Husain AM. Levetiracetam in children with refractory status epilepticus. Epilepsy Behav. 2009;14(1):215–8.

    Article  PubMed  Google Scholar 

  15. Zheng F, Du C, Wang X. Levetiracetam for the treatment of status epilepticus. Expert Rev Neurother. 2015;15(10):1113–21.

    Article  CAS  PubMed  Google Scholar 

  16. Wasterlain CG, Baldwin R, Naylor DE, Thompson KW, Suchomelova L, Niquet J. Rational polytherapy in the treatment of acute seizures and status epilepticus. Epilepsia. 2011;52(Suppl 8):70–1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Caraballo RH, Flesler S, Armeno M, et al. Ketogenic diet in pediatric patients with refractory focal status epilepticus. Epilepsy Res. 2014;108(10):1912–6.

    Article  PubMed  Google Scholar 

  18. Thakur KT, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology. 2014;82(8):665–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Chiusolo F, Diamanti A, Bianchi R, et al. From intravenous to enteral ketogenic diet in PICU: a potential treatment strategy for refractory status epilepticus. Eur J Paediatr Neurol. 2016;20(6):843–7.

    Article  CAS  PubMed  Google Scholar 

  20. Farias-Moeller R, Bartolini L, Pasupuleti A, et al. A practical approach to ketogenic diet in the pediatric intensive care unit for super-refractory status epilepticus. Neurocrit Care. 2016;26(2):267–72.

    Article  Google Scholar 

  21. Appavu B, Vanatta L, Condie J, et al. Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure. 2016;41:62–5.

    Article  PubMed  Google Scholar 

  22. Orlowski JP, Erenberg G, Lueders H, Cruse RP. Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med. 1984;12(4):367–72.

    Article  CAS  PubMed  Google Scholar 

  23. Yang X, Wang X. Potential mechanisms and clinical applications of mild hypothermia and electroconvulsive therapy on refractory status epilepticus. Expert Rev Neurother. 2015;15(2):135–44.

    Article  CAS  PubMed  Google Scholar 

  24. Corry JJ, Dhar R, Murphy T, Diringer MN. Hypothermia for refractory status epilepticus. Neurocrit Care. 2008;9:189–97.

    Article  CAS  PubMed  Google Scholar 

  25. Guilliams K, Rosen M, Buttram S, et al. Hypothermia for pediatric refractory status epilepticus. Epilepsia. 2013;54(9):1586–94.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Lin JJ, Lin KL, Hsia SH, Wang HS. Therapeutic hypothermia for febrile infection-related epilepsy syndrome in two patients. Pediatr Neurol. 2012;47(6):448–50.

    Article  PubMed  Google Scholar 

  27. AIF S. College guidelines on electroconvulsive therapy: an update for prescribers. Adv Psychiatr Treat. 2005;11(2):150–6.

    Article  Google Scholar 

  28. Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012;135(Pt 8):2314–28.

    PubMed  Google Scholar 

  29. Lomber SG, Payne BR, Horel JA. The cryoloop: an adaptable reversible cooling deactivation method for behavioral or electrophysiological assessment of neural function. J Neurosci Methods. 1999;86(2):179–94.

    Article  CAS  PubMed  Google Scholar 

  30. Shin HW, O'Donovan CA, Boggs JG, et al. Successful ECT treatment for medically refractory nonconvulsive status epilepticus in pediatric patient. Seizure. 2011;20(5):433–6.

    Article  PubMed  Google Scholar 

  31. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia. 2000;41(Suppl 2):S23–30.

    Article  PubMed  Google Scholar 

  32. Legriel S, Mourvillier B, Bele N, et al. Outcomes in 140 critically ill patients with status epilepticus. Intensive Care Med. 2008;34:476–80.

    Article  PubMed  Google Scholar 

  33. Legriel S, Azoulay E, Resche-Rigon M, et al. Functional outcome after convulsive status epilepticus. Crit Care Med. 2010;38:2295–303.

    Article  PubMed  Google Scholar 

  34. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry. 2006;77:611–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Scholtes FB, Renier WO, Meinardi H. Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients. Epilepsia. 1994;35:1104–12.

    Article  CAS  PubMed  Google Scholar 

  36. Jehi L, Najm IM. Sudden unexpected death in epilepsy: impact, mechanisms, and prevention. Cleve Clin J Med. 2008;75(Suppl2):s66–70.

    Article  PubMed  Google Scholar 

  37. Téllez-Zenteno JF, et al. Sudden unexpected death in epilepsy: evidence-based analysis of incidence and risk factors. Epilepsy Res. 2005;65(1–2):101–15.

    Article  PubMed  Google Scholar 

  38. Ficker DM, et al. Population-based study of the incidence of sudden unexp1ained death in epilepsy. Neurology. 1998;51(5):1270–4.

    Article  CAS  PubMed  Google Scholar 

  39. Tellez-Zenteno JF, Ronquillo LH, Wiebe S. Sudden unexpected death in epilepsy: evidence-based analysis of incidence and risk factors. Epilepsy Res. 2005;65:101–15.

    Article  PubMed  Google Scholar 

  40. Wasterlain CG, Fujikawa DG, Penix L, et al. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia. 1993;34(Suppl 1):S37–53.

    Article  PubMed  Google Scholar 

  41. Engrand N, Crespel A, et al. Pathophysiologic basis of status epilepticus. Rev Neurol (Paris). 2009;165(4):315–9.

    Article  CAS  Google Scholar 

  42. Garzon E, Fernandes RM, Sakamoto AC. Analysis of clinical characteristics and risk factors for mortality in human status epilepticus. Seizure. 2003;12(6):337–45.

    Article  PubMed  Google Scholar 

  43. Hocker S. Systemic complications of status epilepticus—an update. Epilepsy Behav. 2015;49:83–7.

    Article  PubMed  Google Scholar 

  44. Hampel KG, Jahanbekam A, Elger CE, et al. Seizure-related modulation of systemic arterial blood pressure in focal epilepsy. Epilepsia. 2016;57(10):1709–18.

    Article  CAS  PubMed  Google Scholar 

  45. Freeman R, Schachter SC. Autonomic epilepsy. Semin Neurol. 1995;15:158–66.

    Article  CAS  PubMed  Google Scholar 

  46. Oppenheimer SM, Gelb A, Girvin JP, et al. Cardiovascular effects of human insular cortex stimulation. Neurology. 1992;42:1727–32.

    Article  CAS  PubMed  Google Scholar 

  47. Manno EM, Pfeifer EA, Cascino GD, Noe KH, et al. Cardiac pathology in status epilepticus. Ann Neurol. 2005;58(6):954–7.

    Article  PubMed  Google Scholar 

  48. Surges R, Taggart P, Sander JW, et al. Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death. Epilepsia. 2010;51(5):738–44.

    Article  PubMed  Google Scholar 

  49. Metcalf CS, Poelzing S, Little JG, et al. Status epilepticus induces cardiac myofilament damage and increased susceptibility to arrhythmias in rats. Am J Physiol Heart Circ Physiol. 2009;297(6):H2120–7.

    Article  CAS  PubMed  Google Scholar 

  50. Bealer SL, Little JG, Metcalf CS, et al. Autonomic and cellular mechanisms mediating detrimental cardiac effects of status epilepticus. Epilepsy Res. 2010;91(1):66–73.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Britton J, Gheating GR, Benarroch EE, et al. The ictal bradycardia syndrome: localization and lateralization. Epilepsia. 2006;47:737–44.

    Article  PubMed  Google Scholar 

  52. Zubair S, Arshad AB, Saeed B, et al. Ictal asystole-late manifestation of partial epilepsy and importance of cardiac pacemaker. Seizure. 2009;18:457–61.

    Article  PubMed  Google Scholar 

  53. Lee DJ, Amini M, Hamamura MJ, et al. Aquaporin-4-dependent edema clearance following status epilepticus. Epilepsy Res. 2012;98(2–3):264–8.

    Article  CAS  PubMed  Google Scholar 

  54. Seitelberger F, Lassmann H, Hornykiewicz O. Some mechanisms of brain edema studied in a kainic acid model. Acta Neurobiol Exp (Wars). 1990;50(4–5):263–7.

    CAS  Google Scholar 

  55. Lechner C, Auer D, Kümpfel T, et al. Prolonged non-convulsive status epilepticus as an early clinical manifestation of epilepsy in connection with HIV infection—case report with EEG and MRI follow-up. Fortschr Neurol Psychiatr. 1998;66(7):326–30.

    Article  CAS  PubMed  Google Scholar 

  56. Bailey B, Blais R, Letarte A. Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death. Ann Emerg Med. 2004;44(4):401–6.

    Article  PubMed  Google Scholar 

  57. Schuele SU. Effects of seizures on cardiac function. J Clin Neurophysiol. 2009;26:302–8.

    Article  PubMed  Google Scholar 

  58. Mukherjee S, Tripathi M, Chandra PS, et al. Cardiovascular autonomic functions in well-controlled and intractable partial epilepsies. Epilepsy Res. 2009;85(2–3):261–9.

    Article  PubMed  Google Scholar 

  59. Brambrink AM, Dick WF. Neurogenic pulmonary edema. Pathogenesis, clinical picture and therapy. Anaesthesist. 1997;46(11):953–63.

    Article  CAS  PubMed  Google Scholar 

  60. Johnston SC, Horn JK, Valente J, Simon RP. The role of hypoventilation in a sheep model of epileptic sudden death. Ann Neurol. 1995;37(4):531–7.

    Article  CAS  PubMed  Google Scholar 

  61. Heled Y, Zarian A, Moran D, et al. Exercise induced rhabdomyolysis-characteristics,mechanisms and treatment. Harefuah. 2005;144(1):34–38, 7O.

    PubMed  Google Scholar 

  62. Seyal M, Bateman LM, Albertson TE, et al. Respiratory changes with seizures in localization-related epilepsy: analysis of periictal hypercapnia and airflow patterns. Epilepsia. 2010;51(8):1359–64.

    Article  PubMed  Google Scholar 

  63. Nguyen TT, Hussain E, Grimason M, et al. Neurogenic pulmonary edema and acute respiratory distress syndrome in a healthy child with febrile status epilepticus. J Child Neurol. 2013;28(10):1287–91.

    Article  PubMed  Google Scholar 

  64. Surges R, Thijs RD, Tan HL, et al. Sudden unexpected death in epilepsy: risk factors and potential pathomechanisms. Nat Rev Neurol. 2009;5(9):492–504.

    Article  CAS  PubMed  Google Scholar 

  65. So EL, Sam MC, Lagerlund TL. Postictal central apnea as a cause of SUDEP: evidence from near-SUDEP incident. Epilepsia. 2000;41(11):1494–7.

    Article  CAS  PubMed  Google Scholar 

  66. Walczak T, et al. Do antiepileptic drugs play a role in sudden unexpected death in epilepsy? Drug Saf. 2003;26(10):673–83.

    Article  CAS  PubMed  Google Scholar 

  67. Kumar G, Kalita J, Misra UK. Raised intracranial pressure in acute viral encephalitis. Clin Neurol Neurosurg. 2009;111(5):399–406.

    Article  PubMed  Google Scholar 

  68. Worthley LI, Thomas PD. Treatment of hyponatraemic seizures with intravenous 29.2% saline. Br Med J (Clin Res Ed). 1986;292(6514):168–70.

    Article  CAS  Google Scholar 

  69. Sharf RE. Seizure from hyponatremia in infants. Early recognition and treatment. Arch Fam Med. 1993;2(6):647–52.

    Article  CAS  PubMed  Google Scholar 

  70. Sakellaridis N, Pavlou E, Karatzas S, et al. Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries. J Neurosurg. 2011;114:545–8.

    Article  CAS  PubMed  Google Scholar 

  71. Francony G, Fauvage B, Falcon D, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med. 2008;36:795–800.

    Article  CAS  PubMed  Google Scholar 

  72. Harutjunyan L, Holz C, Rieger A, et al. Efficiency of 7.2% hypertonic saline hydroxyethyl. Starch 200/0.5 versus mannitol 15% in the treatment of increased intracranial pressure in neurosurgical patients—a randomized clinical trial [ISRCTN62699180]. Crit Care. 2005;9:R530–40.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Ichai C, Armando G, Orban JC, et al. Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med. 2009;35:471–9.

    Article  CAS  PubMed  Google Scholar 

  74. Kamel H, Navi BB, Nakagawa K, et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med. 2011;39:554–9.

    Article  CAS  PubMed  Google Scholar 

  75. Kerwin AJ, Schinco MA, Tepas JJ III, et al. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study. J Trauma. 2009;67:277–82.

    Article  CAS  PubMed  Google Scholar 

  76. Bennett TD, Statler KD, Korgenski EK, et al. Osmolar therapy in pediatric traumatic brain injury. Crit Care Med. 2012;40:208–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Wang Y, Liu PP, Li LY, et al. Hypothermia reduces brain edema, spontaneous recurrent seizure attack, and learning memory deficits in the kainic acid treated rats. CNS Neurosci Ther. 2011;17(5):271–80.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chongqing Key Laboratory of Neurology, Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, 1 YouYi Road, Chongqing, 400016, China

    Xuefeng Wang

Authors
  1. Xuefeng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xuefeng Wang .

Editor information

Editors and Affiliations

  1. Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

    Xuefeng Wang

  2. Institute on Global Health (IGH), Peking University & UN Consultative Committee on Life Science and Human Health (CCLH), Beijing, China

    Shichuo Li

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Wang, X. (2017). Treatment Strategies for Refractory Status Epilepticus. In: Wang, X., Li, S. (eds) Refractory Status Epilepticus. Springer, Singapore. https://doi.org/10.1007/978-981-10-5125-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-5125-8_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-5124-1

  • Online ISBN: 978-981-10-5125-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation